Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REFERENCES<br />
Cedarbaum J. M. and McDowell F. H. (1987) Sixteen-year follow-up <strong>of</strong> 100 patients begun on<br />
levodopa <strong>in</strong> 1968: emerg<strong>in</strong>g problems. Adv. Neurol. 45, 469–472.<br />
Chartier-Harl<strong>in</strong> M. C., Kachergus J., Roumier C., Mouroux V., Douay X., L<strong>in</strong>coln S., Levecque C.,<br />
Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M. and<br />
Destée A. (2004) Alpha-synucle<strong>in</strong> locus duplication as a cause <strong>of</strong> familial Park<strong>in</strong>son's<br />
disease. Lancet 364, 1167–1169.<br />
Chaudhuri K. R., Healy D. G. and Schapira A. H.; National Institute for Cl<strong>in</strong>ical Excellence (2006)<br />
Non-motor symptoms <strong>of</strong> Park<strong>in</strong>son's disease: diagnosis and management. Lancet Neurol.<br />
5, 235–45.<br />
Chen H., Zhang S. M., Hernan M. A., Schwarzschild M. A., Willett W. C., Colditz G. A., Speizer F.<br />
E. and Ascherio A. (2003) Nonsteroidal anti-<strong>in</strong>flammatory drugs and the risk <strong>of</strong> Park<strong>in</strong>son<br />
disease. Arch. Neurol. 60, 1059–1064.<br />
Chesselet M. F. (2007) In vivo alpha-synucle<strong>in</strong> overexpression <strong>in</strong> rodents: a useful model <strong>of</strong><br />
Park<strong>in</strong>son’s disease? Exp. Neurol. 209, 22–27.<br />
Cheung Z. H. and Ip N. Y. (2004) Cdk5: mediator <strong>of</strong> neuronal death and survival, Neurosci. Lett.<br />
361, 47–51.<br />
Cheung Z. H., Fu A. K., Ip N. Y. (2006) Synaptic roles <strong>of</strong> Cdk5: implications <strong>in</strong> higher cognitive<br />
functions and neurodegenerative diseases, Neuron 50, 13–18.<br />
Chiba K., Trevor A. and Castagnoli Jr. N. (1984) Metabolism <strong>of</strong> the neurotoxic tertiary am<strong>in</strong>e,<br />
MPTP, by bra<strong>in</strong> monoam<strong>in</strong>e oxidase. Biochem. Biophys. Res. Commun. 120, 574–578.<br />
Chiba K., Trevor A. J. and Castagnoli Jr. N.(1985) Active uptake <strong>of</strong> MPP + , a metabolite <strong>of</strong> MPTP,<br />
by bra<strong>in</strong> synaptosomes. Biochem. Biophys. Res. Commun 128, 1228–1232.<br />
Chung K. K. (2007) Say NO to neurodegeneration: role <strong>of</strong> S-nitrosylation <strong>in</strong> neurodegenerative<br />
disorders. Neurosignals 15, 307–313.<br />
187